Yahoo Poland Wyszukiwanie w Internecie

Search results

1. www.ncbi.nlm.nih.gov › pmc › articlesThe Effectiveness and Safety of Medical Cannabis for Treating...

   www.ncbi.nlm.nih.gov › pmc › articles

   20 maj 2022 · The results of this study suggest that MC treatment is generally safe for oncology patients and can potentially reduce the burden of associated symptoms with no serious MC-related adverse effects. Keywords: medical use, cannabis, phytocannabinoids, oncology, cancer, prospective.

   • Cannabis‐based medicines and medical cannabis for adults with cancer ...

     To assess the efficacy, tolerability and safety of...

   • Medical Cannabis Use in Oncology - StatPearls - NCBI Bookshelf

     Objectives: Describe the pharmacodynamics of medical...

2. ascopubs.org › doi › 10Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline

   ascopubs.org › doi › 10

   Clinicians should recommend against using cannabis or cannabinoids as a cancer-directed treatment unless within the context of a clinical trial. Cannabis and/or cannabinoids may improve refractory, chemotherapy-induced nausea and vomiting when added to guideline-concordant antiemetic regimens.

3. ascopubs.org › doi › 10Cannabis Use in Patients With Cancer: A Clinical Review

   ascopubs.org › doi › 10

   24 cze 2022 · Several studies support the efficacy of cannabis for various cancer and treatment-related symptoms, such as chemotherapy-induced nausea and cancer pain.

4. www.ncbi.nlm.nih.gov › pmc › articlesCannabis‐based medicines and medical cannabis for adults with...

   www.ncbi.nlm.nih.gov › pmc › articles

   22 lut 2022 · To assess the efficacy, tolerability and safety of cannabis‐based medicines, including medical cannabis, for treating pain and other symptoms in adults with cancer.

5. ascopubs.org › doi › pdfdirectCannabis and Cannabinoids in Adults With Cancer: ASCO Guideline

   ascopubs.org › doi › pdfdirect

   13 mar 2024 · Clini-cians should recommend against using cannabis or cannabinoids as a cancer-directed treatment unless within the context of a clinical trial. Cannabis and/or cannabinoids may improve refractory, chemotherapy-induced nausea and vomiting when added to guideline-concordant anti-emetic regimens.

6. www.ncbi.nlm.nih.gov › books › NBK572067Medical Cannabis Use in Oncology - StatPearls - NCBI Bookshelf

   www.ncbi.nlm.nih.gov › books › NBK572067

   27 mar 2023 · Objectives: Describe the pharmacodynamics of medical marijuana. Identify the active compounds within the cannabis plant that hold potential therapeutic benefits within the field of oncology. Outline the potential adverse events a patient may experience while consuming medical marijuana.

7. link.springer.com › article › 10MASCC guideline: cannabis for cancer-related pain and risk ... -...

   link.springer.com › article › 10

   • Zapisane w pamięci cache

   6 mar 2023 · The MASCC panel recommends against the use of cannabinoids as an adjuvant analgesic for cancer pain and suggests that the potential risk of harm and adverse events be carefully considered for all cancer patients, particularly with treatment with a checkpoint inhibitor.